Multi-modal cancer therapy using viral hitchhiking

Cancer therapies based on immunological methods are a rapidly expanding field of cancer treatment options. However, one major problem immunebased cancer therapies face is that cancer cells manage to escape immunological control during their evolution. Methods enabling the immune system to rerecognize tumor cells are therefore an essential part of immune cancer therapies. The present invention is based on a fusion protein that substantially enhances the tumordestroying effect of T-cells against tumor cells marked with Newcastle disease virus (NDV).

Further Information: PDF

DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955

Contact
Dr. Ruth Herzog

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Webb captures top of iconic horsehead nebula in unprecedented detail

NASA’s James Webb Space Telescope has captured the sharpest infrared images to date of a zoomed-in portion of one of the most distinctive objects in our skies, the Horsehead Nebula….

Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes

Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…

Novel genetic plant regeneration approach

…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation.  For ages now, plants have been the…

Partners & Sponsors